Analyst Downgrades – AbbVie (NYSE:ABBV) Stock Gets Downgraded By BMO Capital Markets from Market Perform to Underperform

ME Staff
-
0

Analyst Ratings For AbbVie (NYSE:ABBV)

Today, AbbVie (NYSE:ABBV) stock was downgraded by BMO Capital Markets from Market Perform to Underperform.

Some recent analyst ratings include

  • 1/29/2018-BMO Capital Markets was Downgraded by analysts at BMO Capital Markets from a “Market Perform ” rating to a ” Underperform” rating.
  • 1/29/2018-Leerink Swann was Downgraded by analysts at Leerink Swann from a “Outperform ” rating to a ” Market Perform” rating.

Dividend information for AbbVie (NYSE:ABBV)

AbbVie (NYSE:ABBV) pays an annual dividend of $2.84 with a yield of 2.30% and an average dividend growth of 15.50% based on a 3 Year Average..

Dividend History for AbbVie (NYSE:ABBV)

  • On 10/27/2017 AbbVie announced a Quarterly dividend of $0.71 3.12% with an ex dividend date of 1/11/2018 which will be payable on 2/15/2018.
  • On 9/8/2017 AbbVie announced a Quarterly dividend of $0.64 2.94% with an ex dividend date of 10/12/2017 which will be payable on 11/15/2017.
  • On 6/23/2017 AbbVie announced a quarterly dividend of $0.64 3.52% with an ex dividend date of 7/12/2017 which will be payable on 8/15/2017.
  • On 2/17/2017 AbbVie announced a quarterly dividend of $0.64 4.14% with an ex dividend date of 4/11/2017 which will be payable on 5/15/2017.
  • On 10/28/2016 AbbVie announced a quarterly dividend of $0.64 4.44% with an ex dividend date of 1/11/2017 which will be payable on 2/15/2017.
  • On 9/12/2016 AbbVie announced a quarterly dividend of $0.57 3.56% with an ex dividend date of 10/12/2016 which will be payable on 11/15/2016.
  • On 6/17/2016 AbbVie announced a quarterly dividend of $0.57 3.8% with an ex dividend date of 7/13/2016 which will be payable on 8/15/2016.

Recent Insider Trading Activity For AbbVie (NYSE:ABBV)
AbbVie (NYSE:ABBV) has insider ownership of 0.23% and institutional ownership of 69.28%.

  • On 12/18/2017 Timothy J Richmond, SVP, sold 87,040 with an average share price of $98.45 per share and the total transaction amounting to $8,569,088.00.
  • On 12/15/2017 Laura J Schumacher, Insider, sold 145,510 with an average share price of $96.71 per share and the total transaction amounting to $14,072,272.10.
  • On 11/21/2017 Richard A Gonzalez, Chairman, sold 218,193 with an average share price of $94.01 per share and the total transaction amounting to $20,512,323.93.
  • On 11/10/2017 Michael Severino, EVP, sold 25,633 with an average share price of $94.69 per share and the total transaction amounting to $2,427,188.77.
  • On 10/30/2017 Henry O Gosebruch, Insider, sold 18,300 with an average share price of $90.55 per share and the total transaction amounting to $1,657,065.00.
  • On 9/28/2017 Robert A Michael, VP, sold 6,699 with an average share price of $88.00 per share and the total transaction amounting to $589,512.00.
  • On 9/11/2017 Azita Saleki-Gerhardt, SVP, sold 8,300 with an average share price of $85.02 per share and the total transaction amounting to $705,666.00.

Recent Trading Activity for AbbVie (NYSE:ABBV)
Shares of AbbVie closed the previous trading session at 123.78 up +0.61 0.50% with 121.0999984741211 shares trading hands.